New York Life Investment Management’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,181
Closed -$678K 807
2025
Q3
$678K Sell
16,181
-598
-4% -$26.3K 0.01% 729
2025
Q2
$738K Sell
16,779
-455
-3% -$20.6K 0.01% 699
2025
Q1
$868K Sell
17,234
-15
-0.1% -$744 0.01% 672
2024
Q4
$741K Sell
17,249
-1,657
-9% -$69.9K 0.01% 723
2024
Q3
$741K Sell
18,906
-1,539
-8% -$55.7K 0.01% 763
2024
Q2
$658K Buy
20,445
+3,670
+22% +$118K 0.01% 771
2024
Q1
$553K Sell
16,775
-1,073
-6% -$37.3K 0.01% 778
2023
Q4
$620K Buy
+17,848
New +$616K 0.01% 763

Other funds holding G

New York Life Investment Management's G Position: Q4 2025 in Review

New York Life Investment Management sold out of Genpact (G) in Q4 2025, closing a stake of 16,181 shares — an estimated $678K sold.

New York Life Investment Management first reported a position in G in Q4 2023 and held it in 8 quarters. The position peaked at $868K in Q1 2025. 522 funds tracked by Wall St. Rank hold G as of Q4 2025.

  • New York Life Investment Management reported no remaining Genpact position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 16,181 Genpact shares in Q4 2025, an estimated $678K.
  • New York Life Investment Management first reported a position in Genpact in Q4 2023 and held it in 8 quarters.
  • New York Life Investment Management's Genpact position peaked at $868K in Q1 2025.
  • 522 funds tracked by Wall St. Rank held Genpact as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.